4SC AG Sustainability Reports
4SC AG was historically a biopharmaceutical company focused on the development of small-molecule drugs for cancer indications. Following negative regulatory decisions, the company ceased all research and development efforts and currently maintains no active operational business.
Sector: Manufacturing
Country: Germany
Exchange: Börse Frankfurt
LEI: 391200QOKN7LGVP0RQ86
FIGI: BBG001SKJVW8
11 reports from 2014 to 2024
